Stock market week-in-review for 5 large GI companies — Aug. 7-11

Written by Eric Oliver | August 15, 2017 | Print  |

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of Aug. 7 to Aug. 11, 2017.

Note: This data was compiled using Google Finance.

1. Allergan Pharmaceuticals

Opened: $242.55 on Aug. 7
Peaked: $245.23 on Aug. 8
Closed: $232.88 on Aug. 11
Percent change between Aug 7 to Aug. 11: -3.98 percent

2. Exact Sciences Corp.

Opened: $38.69 on Aug. 7
Peaked: $39.75 on Aug. 7
Closed: $37.76 on Aug. 11
Percent change between Aug 7 to Aug. 11: -2.40 percent

3. Johnson & Johnson

Opened: $133.11 on Aug. 7
Peaked: $134.41 on Aug. 11
Closed: $133.27 on Aug. 11
Percent change between Aug 7 to Aug. 11: 0.12 percent

4. Synergy Pharmaceuticals

Opened: $3.73 on Aug. 7
Peaked: $3.86 on Aug. 8
Closed: $2.96 on Aug. 11
Percent change between Aug 7 to Aug. 11: -20.64 percent

5. Valeant Pharmaceuticals

Opened: $15.09 on Aug. 7
Peaked: $16.89 on Aug. 8
Closed: $13.87 on Aug. 11
Percent change between Aug 7 to Aug. 11: -8.08 percent

More articles on gastroenterology: 
GI center to know: GastroIntestinal Health
Stock market week-in-review for 4 large ASC chains — Aug. 7-11
GI leader to know: Dr. Neil Price of GastroIntestinal Health

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.